sur IKONISYS (EPA:ALIKO)
Aliko Scientific Launches U.S. Business Collaboration at ADLM 2026
Aliko Scientific initiated a collaboration with Partner International at ADLM 2026, the world's largest molecular diagnostics exhibition. This partnership aims to expand Aliko's market presence in the United States, offering direct access to key diagnostics industry players. The event, held in Anaheim, California, generated significant interest in Aliko's technologies, indicating potential for future business development.
The collaboration focuses on identifying new customers, distributors, and strategic partners in the U.S. market. Additionally, discussions have opened avenues for broader international expansion. Partner International will assist Aliko in securing distributorships, forming strategic partnerships, and exploring technology integration opportunities globally.
The U.S. market is a priority for Aliko Scientific, known for its innovations in oncology diagnostics and its integrated portfolio supporting diagnostic workflows. The initiative aligns with Aliko's strategy to enhance its international footprint and establish new distribution channels.
R. P.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de IKONISYS